Balyasny Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26,841	Closed	-$48K	–	3497
2022 Q2	$48K	Buy	+26,841	New	+$39.6K	﹤0.01%	2376
2020 Q4	–	Hold	0	–	–	–	1896
2020 Q3	–	Sell	-11,569	Closed	-$69.2K	–	1751
2020 Q2	$78K	Buy	+11,569	New	+$87.6K	﹤0.01%	1065
2019 Q3	–	Sell	-392,919	Closed	-$5.84M	–	1753
2019 Q2	$5.84M	Sell	392,919 -31,180	-7%	-$563K	0.04%	553
2019 Q1	$10.5M	Buy	424,099 +41,381	+11%	+$1.04M	0.08%	368
2018 Q4	$6.87M	Buy	382,718 +78,652	+26%	+$1.61M	0.05%	446
2018 Q3	$8.93M	Sell	304,066 -76,247	-20%	-$2.95M	0.05%	528
2018 Q2	$17.3M	Sell	380,313 -88,853	-19%	-$4.32M	0.09%	346
2018 Q1	$24.8M	Buy	469,166 +155,921	+50%	+$9.1M	0.12%	272
2017 Q4	$21.3M	Sell	313,245 -186,443	-37%	-$13M	0.08%	382
2017 Q3	$41.2M	Buy	499,688 +53,437	+12%	+$4.24M	0.19%	174
2017 Q2	$41.8M	Sell	446,251 -648,420	-59%	-$39.7M	0.2%	154
2017 Q1	$69.7M	Buy	1,094,671 +814,132	+290%	+$49.5M	0.37%	63
2016 Q4	$12.5M	Sell	280,539 -1,130,287	-80%	-$39.8M	0.08%	415
2016 Q3	$50.9M	Buy	1,410,826 +1,335,826	+1,781%	+$28.7M	0.3%	107
2016 Q2	$1.03M	Buy	+75,000	New	+$1.1M	0.01%	743
2016 Q1	–	Sell	-860,204	Closed	-$30.1M	–	1660
2015 Q4	$30.1M	Buy	860,204 +376,923	+78%	+$24.3M	0.23%	139
2015 Q3	$44.4M	Buy	483,281 +417,381	+633%	+$36.1M	0.38%	79
2015 Q2	$5.79M	Sell	65,900 -151,514	-70%	-$13M	0.05%	547
2015 Q1	$16.1M	Buy	+217,414	New	+$15.4M	0.16%	238
2014 Q4	–	Sell	-166,176	Closed	-$7.54M	–	964
2014 Q3	$7.54M	Buy	166,176 +100,533	+153%	+$4.2M	0.1%	366
2014 Q2	$2.72M	Buy	+65,643	New	+$3.38M	0.05%	488